Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mustang Bio Inc (MBIO)

Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,380
  • Shares Outstanding, K 7,299
  • Annual Sales, $ 0 K
  • Annual Income, $ -15,750 K
  • EBIT $ -3 M
  • EBITDA $ -2 M
  • 60-Month Beta 2.14
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.68
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.31
  • Most Recent Earnings $-0.07 on 11/07/25
  • Next Earnings Date 03/27/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5306 +64.74%
on 02/05/26
1.1000 -20.54%
on 01/14/26
-0.2159 (-19.81%)
since 01/13/26
3-Month
0.5306 +64.74%
on 02/05/26
1.4300 -38.87%
on 11/28/25
-0.3359 (-27.76%)
since 11/13/25
52-Week
0.5306 +64.74%
on 02/05/26
7.0000 -87.51%
on 07/07/25
-1.7659 (-66.89%)
since 02/13/25

Most Recent Stories

More News
Next-Gen Cancer Treatments Gain Steam Amid Oncology Industry Shakeups

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Cancer rates are climbing across the U.S., with stark disparities from state to state. Recent CDC data...

ONCY : 1.0600 (+26.99%)
INAB : 1.7800 (-3.78%)
ONC.TO : 1.42 (+2.16%)
TNGX : 12.90 (+1.82%)
MBIO : 0.8741 (-3.91%)
ELVN : 26.72 (-1.62%)
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:MBIO),(NASDAQ:VSTM),(NASDAQ:CRDF),(NASDAQ:AZN) EQNX::TICKER_END

ONCY : 1.0600 (+26.99%)
AZN : 205.55 (+0.50%)
ONC.TO : 1.42 (+2.16%)
VSTM : 5.82 (-0.34%)
CRDF : 1.6000 (+1.27%)
MBIO : 0.8741 (-3.91%)
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies

ONCY : 1.0600 (+26.99%)
AZN : 205.55 (+0.50%)
ONC.TO : 1.42 (+2.16%)
VSTM : 5.82 (-0.34%)
CRDF : 1.6000 (+1.27%)
MBIO : 0.8741 (-3.91%)
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma

FBIO : 3.61 (+3.44%)
MBIO : 0.8741 (-3.91%)
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

FBIO : 3.61 (+3.44%)
MBIO : 0.8741 (-3.91%)
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

MBIO : 0.8741 (-3.91%)
Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

MBIO : 0.8741 (-3.91%)
Mustang Bio Announces Closing of $8 Million Public Offering

MBIO : 0.8741 (-3.91%)
Mustang Bio Announces Pricing of $8 Million Public Offering

MBIO : 0.8741 (-3.91%)
Mustang Bio Announces Reverse Stock Split

MBIO : 0.8741 (-3.91%)

Business Summary

Mustang Bio, Inc. a subsidiary of Fortress Biotech, Inc., is a clinical'stage biopharmaceutical company. It focused on the development and commercialization of novel cancer immunotherapy products designed to leverage the patient's own immune system to eliminate cancer cells. Mustang Bio, Inc. is based...

See More

Key Turning Points

3rd Resistance Point 0.9789
2nd Resistance Point 0.9443
1st Resistance Point 0.9092
Last Price 0.8741
1st Support Level 0.8395
2nd Support Level 0.8049
3rd Support Level 0.7698

See More

52-Week High 7.0000
Fibonacci 61.8% 4.5287
Fibonacci 50% 3.7653
Fibonacci 38.2% 3.0019
Last Price 0.8741
52-Week Low 0.5306

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar